Inventor

Paul C. Zamecnik

Inventor

Shrewsbury, MA, US

Overview

21→

Patents

1989–2017

Patent span

Chemistry

Primary field (CPC C)

Patents· 21 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes22%

C12NMicroorganisms or enzymes22%

C07HSugars17%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%

C07KPeptides7%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%

G01NInvestigating or analysing materials by determining their chemical or physical properties4%

Y02ATechnologies for adaptation to climate change4%

B01JChemical or physical processes, e.g. catalysis or colloid chemistry2%

C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture2%

PatentTitleYear

9,617,535'Oligonucleotide complex compositions and methods of use as gene alteration tools'2017 8,841,271'Oligonucleotide complex compositions and methods of use as gene alteration tools'2014 8,314,226'Oligonucleotide complex compositions and methods of use as gene alteration tools'2012 8,084,589'Phosphoramidite nucleoside analogs'2011 6,440,660'Oligonucleotide mediated reversal of drug resistance'2002 6,335,436'Oligonucleotides active against drug-resistant bacteria'2002 6,299,857'Cardiovascular and thrombus imaging agents, methods and kits'2001 5,955,590'Conjugates of minor groove DNA binders with antisense oligonucleotides'1999 5,681,823'P.sup.1, P.sup.4 -dithio-P.sup.2 -P.sup.3 -monochloromethylene 5\', 5\'\"-diadenosine P.sup.1, P.sup.4 -tetraphosphate as antithrombotic agent'1997 5,637,573'Influenza virus replication inhibiting oligonucleotide analogues and their pharmaceutical compositions'1997 5,635,377'Method of site-specific alteration of RNA and production of encoded polypeptides'1997 5,616,564'Antiparasitic oligonucleotides active against drug resistant malaria'1997 5,559,221'Method of separating oligonucleotides from a mixture'1996 5,366,878'Method of site-specific alteration of RNA and production of encoded polypeptides'1994 5,352,578'Method of separating oligonucleotides from a mixture'1994 5,220,007'Method of site-specific alteration of RNA and production of encoded polypeptides'1993 5,194,428'Inhibition of influenza virus replication by oligonucleotide phosphorothioates'1993 5,149,798'Process for synthesizing oligonucleotides and their analogs adaptable to large scale syntheses'1992 5,149,797'Method of site-specific alteration of RNA and production of encoded polypeptides'1992 5,049,550'Diadenosine 5\', 5\'\"-p.sup.1, p.sup.4,-tetraphosphate analogs as antithrombotic agents'1991 4,806,463'Inhibition of HTLV-III by exogenous oligonucleotides'1989

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1989–1999Patents assigned to WORCESTER FOUND EX BIOLOGY (12)· patent assignee history

1989–2002Based in Shrewsbury, MA, US· patent location history

1997Based in Shrewbury, MA, US· patent location history

2001–2014Patents assigned to GEN HOSPITAL CORP (3)· patent assignee history

2002Patents assigned to HYBRIDON INC (2)· patent assignee history

2011–2017Based in Boston, MA, US· patent location history

2012–2014Patents assigned to CANTIELLO HORACIO F (2)· patent assignee history

2012–2014Patents assigned to RAYCHOWDHURY MALAY K (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
WORCESTER FOUND EX BIOLOGY	12	1989–1999
GEN HOSPITAL CORP	3	2001–2014
CANTIELLO HORACIO F	2	2012–2014
HYBRIDON INC	2	2002
RAYCHOWDHURY MALAY K	2	2012–2014

Locations

Location	Patents	Span
Shrewsbury, Massachusetts, US	16	1989–2002
Boston, Massachusetts, US	4	2011–2017
Shrewbury, Massachusetts, US	1	1997